ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Top Brokers

More Brokers

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
AI Sign In Premium IconPremium Help Menu
FTSE 100
8,223.98
-0.44%
Dow Jones
42,732.13
0.80%
Gold vs US Dollar
2,640.60
0.00%
Brent Oil
76.495
0.00%
Bitcoin
97,904.84
-0.21%
Pepperstone
Advertisement
Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ

  6. Apollomics Inc (APLM) Share Price

APLM Apollomics Inc

10.69
-0.11 (-1.02%)
04 Jan 2025 - Closed
Delayed by 15 minutes
 Name  Symbol  Market  Type  ISIN  Description 
 Apollomics Inc NASDAQ:APLM NASDAQ Common Stock  Class A Ordinary Shares
     Change  % Chg  Cur  Bid  Offer  High  Low  Open  Volume  Chg Time
Upgrade Icon
 		 RN  NRN 
   -0.11 -1.02 10.69 6.55 13.99 12.00 10.44 10.48 67,073 01:00:00   
 Sector  Turnover  Profit  EPS - Basic  PE ratio  Mkt Cap 
 Pharmaceutical Preparations 1.22M -172.6M -156.5308 -0.07 11.91M
 Type  Size  Price  Time  Units 
 9 18 10.91 21:30:27 USD
 
Pre-Market and After-Hours
Recent News
DateTimeSource
HeadlineMore APLM News
13/08/202414:50APSBiotech Sees Massive Buying Pressure Following Phase 2 Preliminary Data
04/06/202412:00GLOBEApollomics Announces Vebreltinib Data at the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting
29/05/202412:00GLOBEApollomics Announces Presentation at the 2024 BIO International Convention
08/05/202420:05GLOBEApollomics Announces Private Placement Financing and Addition to Board of Directors
25/04/202412:30GLOBEApollomics Announces Approval of Vebreltinib in China as a First-in-Class Treatment for Gliomas with MET Fusion Gene
10/04/202411:00GLOBEApollomics Presents Vebreltinib Data at the 2024 American Association for Cancer Research (AACR) Annual Meeting
02/04/202412:00GLOBEApollomics Announces Poster Presentations of Vebreltinib Data at the 2024 American Association for Cancer Research (AACR) Annual Meeting
Period
Draw mode
Data Downloads for APLM

Export historical price information open, high, low, close, volume (OHLCV) to Excel

Intraday price data (2 weeks, 1 minute bars)


Loading Follow Feed...

Latest Apollomics Inc Articles

Go Ad-Free

Subscribe to Ad free and enjoy an ad-free experience

No Ads

Try Now

Keep the Ads